- 19 patent applications filed in the United States and internationally (under the Patent Cooperation Treaty), with national filings in 44 countries
- Collaborative research and development agreement with Canada’s National Research Council to investigate opportunities associated with bioavailability enhancement of certain compounds, including those in cannabinoids, vitamins, NSAIDs and nicotine
- Out-licenses its patented technology to third party partners, with several deals signed or pending
When Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) researchers tackled the issue facing consumers of edible cannabinoids – poor absorption of the product’s bioactive compounds by the body’s gastrointestinal tract – an important statement led the way: bioavailability matters. The company realized that if hemp oil ingredients were infused within lipids found in popular foods, the common problems of bad taste, poor absorption in the body and lack of product variety could be solved.
Lexaria has since developed a superior method of lipid-delivery technology through a patented process that does this by infusing the beneficial elements of hemp oil to lipid molecules. Lexaria reminds consumers that it is not mixing hemp oil into a product; it is infusing organically sourced, high purity hemp oil inside the molecules of other ingredients to produce superior tasting and performing food and beverages, including premium teas, protein energy bars and hemp oil capsules formulated with ginseng and ginkgo for enhanced memory and focus.
Read the full article
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer